- Research

New guidelines for parasite studies using extracellular vesicles

A collaborative document outlining new guidelines for the isolation and characterisation of extracellular vesicles in parasitic disease research has been published in the Journal of Extracellular Biology. A research group from IGTP and ISGlobal contributed to the study, which could enhance our understanding of host-parasite interactions and advance early diagnosis, treatment, and prevention of parasite-caused diseases.

- Research

Apotransferrin shows promise as an early treatment for stroke

Researchers from IGTP have discovered that administering human apotransferrin to mice models affected by intracerebral haemorrhage can mitigate the damaging effects of this severe type of stroke. This finding highlights the promising role of apotransferrin as a pre-hospital and pre-triage frontline treatment for all stroke patients. The study has been published in the journal Antioxidants.

- Research

Type 1 diabetes research sheds light on biomarkers in partial remission phase

Researchers from the IGTP have led a comprehensive review study on biomarkers for the often-overlooked partial remission phase of type 1 diabetes, in collaboration with experts in β-cell biology and regeneration from the Diabetes Research Institute in Miami. The study has been published in the journal Trends in Endocrinology and Metabolism.

GCAT takes part in one of the projects funded by Fundació La Marató de 3Cat

The funds raised in the 2022 edition of La Marató de 3Cat will enable 71 research teams to conduct 37 projects in cardiovascular health to advance in the prevention, diagnosis, and treatment of diseases that represent the leading cause of death in developed countries. One of the awarded projects involves the participation of researchers from the GCAT of the IGTP, and is coordinated by Dr Camille Lassale from ISGlobal.

Two projects from IGTP funded by ”la Caixa” Foundation to transition their innovative research from the laboratory to patients

The first urine test that detects kidney fibrosis as an alternative to kidney biopsies, an initiative from the IVECAT group, and a project applying artificial intelligence to rapidly categorise stroke patients and enhance their recovery chances, from the Neurovascular Research group, are two of the fifteen projects from Catalan research centres selected within the 2023 call of the new CaixaImpulse Healthcare Innovation programme.